16 WashU anesthesiology residents present at MARC 2026
Sixteen residents from the Department of Anesthesiology at WashU Medicine presented their research at the 2026 Midwest Anesthesia Resident Conference (MARC), held April 17-19 in Cleveland, Ohio.
Celebrating Inclusive Behaviors: Anesthesiology Department Recognizes SAFE Reporting Accolade Recipients
The Department of Anesthesiology is proud to recognize team members who have received accolades through the SAFE (Supporting a Fair Environment) Reporting platform.
Goldfarb ranked in top 10 programs for nursing anesthesia (Links to an external site)
Barnes-Jewish College Goldfarb School of Nursing’s Certified Registered Nurse Anesthetist (CRNA) program ranked No. 9 in the country in U.S. News & World Report’s 2026 ranking of the Best Nursing-Anesthesia Schools.
Highlights from the Fourth Annual Supporting Women of WUDA Retreat
The Supporting Women of WUDA (WashU Medicine Department of Anesthesiology) group hosted its fourth annual retreat on Saturday, April 11, at the Whittemore House on WashU’s Danforth Campus. Colleagues from across the department gathered for a morning of connection over breakfast, followed by programming focused on reflection and practical application.
Six department faculty honored with 2026 Dean’s Impact Awards
Congratulations to the six Department of Anesthesiology faculty members who have been selected for the 2026 Dean’s Impact Award.
Environmental enrichment reduces fentanyl relapse in rats (Links to an external site)
A study by WashU Medicine researchers offers new insight into how environmental factors protect against opioid addiction and support recovery.
Gereau receives Ray Dingledine Award for Research Impact
Robert W. Gereau IV, PhD, the Dr. Seymour and Rose T. Brown Professor and vice chair for research in the Department of Anesthesiology at WashU Medicine, received the Ray Dingledine Award for Research Impact on March 6, 2026.
Study uncovers how delta opioid receptor could be harnessed for safer pain therapeutics
Sarah Bernhard, PhD, and Susovan Chowdhury, PhD, co-led a study showing how the delta opioid receptor could be targeted to develop safer, more effective pain treatments.